BRCAL 用于测试的成本 翻译结果4复制译文编辑译文朗读译文返回顶部 测试的费用BRCAL的 翻译结果5复制译文编辑译文朗读译文返回顶部 测试的费用对于BRCAL 相关内容 a因为内疚,所以想用爱补偿,可那并不是爱,好辛苦 Because of compunction, therefore wants to use to like compensating, but that is not a love, ...
The article reports possibility that cost of breast cancer (BRCA) gene testing will decline after the U.S. Supreme Court invalidated BRCA patent claims of molecular diagnostics firm Myriad Genetics. Several rival companies including Ambry Genetics, Quest Diagnostics, and GeneDx reportedly announced ...
Compared with no testing,BRCAtesting of affected women resulted in an incremental cost per quality-adjusted life-year (QALY) gained of AU$18,900 (incremental cost AU$1,880; incremental QALY gain 0.10) with reductions of 0.04 breast and 0.01 ovarian cancer events. Testing affected women and cas...
Testing for the BRCA1 and BRCA2 Breast-Ovarian Cancer Susceptibility Genes A Decision Analysis OBJECTIVE: The authors developed a Markov decision model to evaluate the health implications of testing for mutations in the BRCA1 and BRCA2 breast-ovarian... TO Tengs,EP Winer,S Paddock,... - 《Me...
Counseling and predictive testing are now available for the recently isolated BRCA1 and BRCA2 breast cancer susceptibility genes. We examined the societal costs of providing this counseling and testing to women at risk of having a breast cancer susceptibility mutation. Genetic counselors in a research...
Our results on genetic testing for breast cancer show that DS is not the most cost-effective method available. The monopolist approach of the firm which owns the patents on the BRCA1/2 genes, may, therefore limit the use of the most cost-effective strategies. 展开 关键词:...
A. The cost of testing for BRCA 1 and BRCA 2 is very expensive in America. B. The chances of getting breast cancer will drop slightly if someone has a mastectomy. C. It is not easy to have a mastectomy, but it is a worthwhile choice. ...
Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. J Natl Cancer Inst. 2018;110(7):714-725. doi:10.1093/jnci/djx265PubMedGoogle ScholarCrossref 32. Thompson ER, Gorringe KL, Rowley SM...
ARTICLE Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: A call for dialogue Wendy S. Rubinstein, MD, PhD1,2,3, Hongmei Jiang, PhD3,4, Lisa Dellefave, MS5, and Alfred W. Rademaker, PhD3,6 Purpose: About half of unaffected BRCA1/...
The artificial nature of the survey might have implied, however, that no further family history existed to be disclosed, so we cannot comment on whether second degree relative information would be requested in reality. How access to adverse test results for BRCA1 or BRCA2 would influence the ...